OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury
Juliette Hordeaux, Jason Lamontagne, Chunjuan Song, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 952-968
Closed Access | Times Cited: 14
Juliette Hordeaux, Jason Lamontagne, Chunjuan Song, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 952-968
Closed Access | Times Cited: 14
Showing 14 citing articles:
Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches
Nuria Bara-Ledesma, Adrián Viteri-Noël, M. López Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 578-578
Open Access | Times Cited: 2
Nuria Bara-Ledesma, Adrián Viteri-Noël, M. López Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 578-578
Open Access | Times Cited: 2
Innate Immune Sensing of AAV Vectors
Di Cao, Barry J. Byrne, Ype P. de Jong, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 13-14, pp. 451-463
Closed Access | Times Cited: 10
Di Cao, Barry J. Byrne, Ype P. de Jong, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 13-14, pp. 451-463
Closed Access | Times Cited: 10
Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference?
Ashley L. Harkins, Prajakta P Ambegaokar, Allison M. Keeler
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00435-e00435
Open Access | Times Cited: 6
Ashley L. Harkins, Prajakta P Ambegaokar, Allison M. Keeler
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00435-e00435
Open Access | Times Cited: 6
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials
Jasna Metović, Yedda Li, Yi Gong, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00443-e00443
Open Access | Times Cited: 4
Jasna Metović, Yedda Li, Yi Gong, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00443-e00443
Open Access | Times Cited: 4
Duchenne muscular dystrophy, one of the most complicated diseases for gene therapy
Serge Braun
Journal of Translational Genetics and Genomics (2025) Vol. 9, Iss. 1, pp. xx-xx
Open Access
Serge Braun
Journal of Translational Genetics and Genomics (2025) Vol. 9, Iss. 1, pp. xx-xx
Open Access
A single amino acid variant in the variable region I of AAV capsid confers liver detargeting
Ruxiao Xing, Mengyao Xu, Darcy Reil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Ruxiao Xing, Mengyao Xu, Darcy Reil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Single Cell and Spatial Omics and Applications in Toxicology
David A. Gallegos, Dakota R. Robarts, David S. Umbaugh
Elsevier eBooks (2025)
Closed Access
David A. Gallegos, Dakota R. Robarts, David S. Umbaugh
Elsevier eBooks (2025)
Closed Access
Liver gene transfer for metabolite detoxification in inherited metabolic diseases
A. D’Alessio, Iolanda Boffa, Lucia De Stefano, et al.
FEBS Letters (2024)
Open Access | Times Cited: 3
A. D’Alessio, Iolanda Boffa, Lucia De Stefano, et al.
FEBS Letters (2024)
Open Access | Times Cited: 3
Adeno-associated Virus (AAV) vectors - a target of cellular and humoral immunity – are expanding their reach towards hematopoietic stem cell modification and immunotherapies
Angela E. Araujo, Martin Bentler, Xabier Perez Garmendia, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 17-18, pp. 586-603
Closed Access | Times Cited: 2
Angela E. Araujo, Martin Bentler, Xabier Perez Garmendia, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 17-18, pp. 586-603
Closed Access | Times Cited: 2
Systemic Toxicity of Recombinant Adeno-Associated Virus Gene Therapy Vectors
Basel T. Assaf
Toxicologic Pathology (2024)
Closed Access | Times Cited: 1
Basel T. Assaf
Toxicologic Pathology (2024)
Closed Access | Times Cited: 1
Current and Emerging Issues in Adeno-Associated Virus Vector-Mediated Liver-Directed Gene Therapy
Pasquale Piccolo, Nicola Brunetti‐Pierri
Human Gene Therapy (2024)
Closed Access | Times Cited: 1
Pasquale Piccolo, Nicola Brunetti‐Pierri
Human Gene Therapy (2024)
Closed Access | Times Cited: 1
The role of TBC1D15 in sepsis-induced acute lung injury: Regulation of mitochondrial homeostasis and mitophagy
Hanghang Han, Yingying Zhang, Enhao Huang, et al.
International Journal of Biological Macromolecules (2024) Vol. 293, pp. 139289-139289
Closed Access | Times Cited: 1
Hanghang Han, Yingying Zhang, Enhao Huang, et al.
International Journal of Biological Macromolecules (2024) Vol. 293, pp. 139289-139289
Closed Access | Times Cited: 1
First, do no harm: the role of preclinical animal models in predicting adverse events in gene therapy clinical trials for Duchenne muscular dystrophy and X-Linked myotubular myopathy
Joe N. Kornegay, Hansell H. Stedman, Michael W. Lawlor, et al.
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 4
Open Access
Joe N. Kornegay, Hansell H. Stedman, Michael W. Lawlor, et al.
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 4
Open Access
Preclinical development of viral vector gene therapies
Mark J. Newman, Eloïse Hudry, Jacqueline Brassard, et al.
Elsevier eBooks (2024), pp. 255-311
Closed Access
Mark J. Newman, Eloïse Hudry, Jacqueline Brassard, et al.
Elsevier eBooks (2024), pp. 255-311
Closed Access
